For the phase III clinical program, a total of eight studies were initiated that investigated the efficacy and safety of tirzepatide in comparison to various other established antidiabetic medications in T2D either in monotherapy, combination with metformin as baseline therapy, or metformin and insulin glargine as a baseline
While the science behind them may sound complex, their purpose is simple: helping your body respond to food in a healthier and more balanced way
Compounded semaglutide and brand-name formulations (Ozempic, Wegovy, Rybelsus) contain the same active molecule
Have you considered taking a GLP-1 receptor agonist
A regulatory filing (NDA/BLA with the FDA, MAA with the EMA) would follow compilation of the complete clinical data package after Phase 3 completion
(SURMOUNT-1) Jastreboff AM, Kaplan LM, Fras JP, et al